The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.
Dr. Bright is a virologist and a former head of the Biomedical Advanced Research and Development Authority. In early 2020, when the first genetic sequence of the new coronavirus was posted online, ...